Show simple item record

dc.contributor.authorHjort, Rebecka
dc.contributor.authorAhlqvist, Emma
dc.contributor.authorCarlsson, Per-Ola
dc.contributor.authorGrill, Valdemar Erik Robert
dc.contributor.authorGroop, Leif
dc.contributor.authorMartinell, Mats
dc.contributor.authorRasouli, Bahareh
dc.contributor.authorRosengren, Anders
dc.contributor.authorTuomi, Tiinamaija
dc.contributor.authorÅsvold, Bjørn Olav
dc.contributor.authorCarlsson, Sofia
dc.date.accessioned2019-03-14T07:34:20Z
dc.date.available2019-03-14T07:34:20Z
dc.date.created2018-07-02T13:21:44Z
dc.date.issued2018
dc.identifier.citationDiabetologia. 2018, 61 (6), 1333-1343.nb_NO
dc.identifier.issn0012-186X
dc.identifier.urihttp://hdl.handle.net/11250/2589921
dc.description.abstractAims/hypothesis Excessive weight is a risk factor for type 2 diabetes, but its role in the promotion of autoimmune diabetes is not clear. We investigated the risk of latent autoimmune diabetes in adults (LADA) in relation to overweight/obesity in two large population-based studies. Methods Analyses were based on incident cases of LADA (n = 425) and type 2 diabetes (n = 1420), and 1704 randomly selected control participants from a Swedish case–control study and prospective data from the Norwegian HUNT Study including 147 people with LADA and 1,012,957 person-years of follow-up (1984–2008). We present adjusted ORs and HRs with 95% CI. Results In the Swedish data, obesity was associated with an increased risk of LADA (OR 2.93, 95% CI 2.17, 3.97), which was even stronger for type 2 diabetes (OR 18.88, 95% CI 14.29, 24.94). The association was stronger in LADA with low GAD antibody (GADA;nb_NO
dc.language.isoengnb_NO
dc.publisherSpringer Verlagnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleOverweight, obesity and the risk of LADA: results from a Swedish case-control study and the Norwegian HUNT Studynb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber1333-1343nb_NO
dc.source.volume61nb_NO
dc.source.journalDiabetologianb_NO
dc.source.issue6nb_NO
dc.identifier.doi10.1007/s00125-018-4596-0
dc.identifier.cristin1595190
dc.description.localcode© The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/),nb_NO
cristin.unitcode194,65,15,0
cristin.unitcode194,65,20,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.unitnameInstitutt for samfunnsmedisin og sykepleie
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal